Advertisement

Topics

Simbec Company Profile

21:22 EDT 24th September 2018 | BioPortfolio

Nil


News Articles [2 Associated News Articles listed on BioPortfolio]

Acticor Biotech Confirms Simbec-Orion to Make Its First in Patient Study in Acute Ischemic Stroke

Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including stroke and pulmonary embolism, as part of the development of ...

ImmuPharma anticipating latest Lupuzor test results in April

Specialist drug discovery and development company ImmuPharma announced on Friday that it has been informed by Simbec-Orion, the contract research organisation conducting its 'Lupuzor' pivotal Phase...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

A Study of SENS 401 in Healthy Subjects

Sensorion are the study sponsor and the objective of this study is to investigate the safety and pharmacokinetic (PK) profile of SENS 401 in humans after a single and repeat dose administr...

A Single Dose PK Study of SENS-218 in Healthy Volunteers

This study is to aid the development for the use of SENS-218 outside its marketed therapeutic indications. SENS-218 is available in Asia and is marketed as an anti-emetic (Anti-sickness) d...

More Information about "Simbec" on BioPortfolio

We have published hundreds of Simbec news stories on BioPortfolio along with dozens of Simbec Clinical Trials and PubMed Articles about Simbec for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Simbec Companies in our database. You can also find out about relevant Simbec Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record